Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Optimi Health Corp

Healthcare CA OPTI

5.9CAD
-1.2(16.90%)

Last update at 2026-06-22T19:58:00Z

Day Range

5.907.11
LowHigh

52 Week Range

0.100.42
LowHigh

Fundamentals

  • Previous Close 7.10
  • Market Cap34.84M
  • Volume10037
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.39200M
  • Revenue TTM0.19M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM -0.23836M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -3.71203M -6.03586M -5.19455M -7.35083M -6.01953M
Minority interest - - - - -
Net income -3.71203M -6.03586M -5.19455M -7.35083M -6.01953M
Selling general administrative 2.72M 3.85M 3.82M 7.02M 5.77M
Selling and marketing expenses - - - - -
Gross profit -0.06813M 0.27M 0.20M 0.05M 0.00000M
Reconciled depreciation 0.95M 0.87M 0.73M 0.29M 0.05M
Ebit - - - -6.92817M -5.35011M
Ebitda - - - -7.02924M -5.95322M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -4.61228M -5.60919M -5.27229M -7.38978M -6.05538M
Other operating expenses - - - - -
Interest expense 0.53M 0.43M 0.04M 0.03M 0.02M
Tax provision - - - - -
Interest income 0.01M 0.00266M 0.14M 0.07M 0.06M
Net interest income -0.51737M -0.42667M 0.09M 0.04M 0.04M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.43M 0.39M 0.18M 0.08M 0.00000M
Total operating expenses 5.04M 6.00M 5.45M 7.47M 6.06M
Cost of revenue 0.49M 0.12M -0.01914M 0.03M 0.00000M
Total other income expense net 1.42M - -0.01496M - -
Discontinued operations - - - - -
Net income from continuing ops -3.71203M -6.03586M -5.19455M -7.35083M -6.01953M
Net income applicable to common shares - - - -7.35083M -6.01953M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 15.21M 14.55M 16.49M 16.82M 23.46M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - 0.01M 0.02M
Total liab 8.64M 4.98M 3.28M 0.80M 2.40M
Total stockholder equity 6.57M 9.58M 13.21M 16.02M 21.07M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - - 26.61M 25.16M
Capital stock 31.69M 31.16M 28.70M 26.61M 25.16M
Retained earnings -27.24168M -23.61083M -17.64502M -13.42708M -6.18875M
Other liab - - - - -
Good will - - - - -
Other assets - - - 0.01M 0.26M
Cash 1.15M 0.10M 1.34M 1.89M 8.43M
Cash and equivalents - - - - -
Total current liabilities 8.48M 3.22M 1.61M 0.73M 2.24M
Current deferred revenue - - - - -
Net debt 5.19M 2.61M 0.29M - -
Short term debt - - - - -
Short long term debt 6.33M 0.96M - - -
Short long term debt total - - - - -
Other stockholder equity - - - 2.83M 2.10M
Property plant equipment - - - 14.38M 8.90M
Total current assets 1.83M 1.23M 2.43M 2.43M 14.30M
Long term investments - - - - -
Net tangible assets - - - 16.02M 21.07M
Short term investments - - - 0.00000M 4.00M
Net receivables 0.10M 0.12M 0.17M 0.10M 0.19M
Long term debt - 1.76M 1.64M - -
Inventory 0.31M 0.89M 0.78M 0.26M 0.12M
Accounts payable 1.19M 0.75M 0.90M 0.56M 2.11M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 13.39M 13.32M 14.06M 14.40M 9.16M
Capital lease obligations 0.18M 0.03M 0.07M 0.16M 0.25M
Long term debt total - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - -0.15402M -0.70602M 4.00M -4.00000M
Change to liabilities - - - 0.12M 0.26M
Total cashflows from investing activities - - - -3.15129M -9.19321M
Net borrowings 3.40M 0.96M 1.92M -0.11124M -0.04906M
Total cash from financing activities 3.76M 3.19M 3.76M 1.19M 19.18M
Change to operating activities - - - 1.51M -1.64326M
Net income -3.71203M -6.03586M -5.19455M -7.35083M -6.01953M
Change in cash 1.04M -1.24112M -0.54380M -6.54427M 3.96M
Begin period cash flow 0.10M 1.34M 1.89M 8.43M 4.47M
End period cash flow 1.15M 0.10M 1.34M 1.89M 8.43M
Total cash from operating activities -2.62790M -4.28169M -3.60154M -4.57954M -6.02327M
Issuance of capital stock 0.40M 2.04M 1.84M 0.00000M 18.86M
Depreciation 0.95M 0.87M 0.73M 0.29M 0.05M
Other cashflows from investing activities - - - - -0.25755M
Dividends paid - - - - -
Change to inventory 0.50M 0.02M -0.21315M -0.26472M -0.26472M
Change to account receivables 0.03M 0.04M -0.06704M 0.09M -0.10496M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - 0.05M
Change to netincome - - - 1.03M 1.44M
Capital expenditures 0.09M 0.15M 0.80M 7.15M 4.94M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.25M 0.76M 0.83M 1.45M -1.48857M
Stock based compensation 0.05M 0.06M 0.16M 1.01M 1.26M
Other non cash items 0.26M 0.07M 0.03M 0.02M 0.18M
Free cash flow -2.71628M -4.43408M -4.40577M -11.73083M -10.95892M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OPTI
Optimi Health Corp		 -1.2 16.90% 5.90 - - 179.96 6.75 206.22 -5.5594
GTII
Green Thumb Industries Inc		 -0.15 1.40% 10.60 14.70 34.84 1.91 0.86 1.61 3.95
CL
Cresco Labs Inc		 -0.07 6.09% 1.08 - 105.26 0.70 0.99 1.32 42.44
JUSH
Jushi Holdings Inc		 -0.01 1.49% 0.66 - 17.86 0.52 0.69 1.41 9.56
GRIN
Grown Rogue International Inc		 0.02 3.33% 0.62 23.50 - 3.62 4.10 3.13 11.19

Reports Covered

Stock Research & News

View All

Profile

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Optimi Health Corp

1200-609 Granville Street, Princeton, BC, Canada, V0X 1W0

Key Executives

Name Title Year Born
Mr. Dane Stevens Co-Founder, CEO, Chief Marketing Officer & Director 1990
Mr. Bryan Edward Safarik Co-Founder, COO & Director 1985
Mr. Jacob Safarik Co-Founder, Interim CFO & Director 1988
Dr. Preston A. Chase Chief Science Officer NA
Ms. Ann Little Human Resources Manager NA
Ms. Leah Hodges Corporate Secretary 1983
Mr. John James Wilson Co-Founder & Chairman 1989
Mr. Dane Stevens Co-Founder, CEO, Chief Marketing Officer & Director 1989
Mr. Jacob Safarik Co-Founder, CFO & Director 1988
Ms. Leah Hodges Corporate Secretary 1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions